|Other names||PEAQX, NVP-AAM077|
|Chemical and physical data|
|Molar mass||454.217 g·mol−1|
|3D model (JSmol)|
|(what is this?)|
PEAQX is a competitive antagonist at the NMDA receptor. Although originally described as 100-fold selective for GluN1/GluN2A receptors vs. GluN1/GluN2B receptors, more detailed studies of the Ki of PEAQX revealed it only shows a 5 fold difference in affinity for GluN1/GluN2A vs. GluN1/GluN2B receptors. It is also a potent anticonvulsant in animal tests.